TY  - JOUR
AU  - Zhang, Xin-Wen
AU  - Mohr, Jutta
AU  - Halama, Niels
AU  - Koschny, Ronald
TI  - Analysis of an Unselected Patient Cohort With Advanced Colorectal Carcinoma from a Maximum Care Center.
JO  - Anticancer research
VL  - 43
IS  - 12
SN  - 0250-7005
CY  - Attiki
PB  - [Verlag nicht ermittelbar]
M1  - DKFZ-2023-02508
SP  - 5589 - 5596
PY  - 2023
N1  - #EA:D240#LA:D240#
AB  - Systemic treatment for metastatic colorectal cancer (CRC) includes chemotherapy in combination with a targeted antibody. Novel targeted therapies and immunotherapies are introduced for specific molecular subgroups. Prognostic relevant determinants are still under investigation.Systemic therapies of an unselected patient cohort with metastatic CRC were retrospectively analyzed. Treatment outcome was evaluated according to time-to-next-treatment (TTNT) and frequency of conversion surgery and compared between subgroups stratified by primary tumor side, molecular profile, sex and age, and metastases sites.More than 50
KW  - Colorectal cancer (Other)
KW  - chemotherapy (Other)
KW  - colorectal liver metastases (Other)
KW  - metastases (Other)
KW  - secondary surgery (Other)
KW  - time-to-next-treatment (Other)
KW  - tumor sidedness (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:38030166
DO  - DOI:10.21873/anticanres.16761
UR  - https://inrepo02.dkfz.de/record/285693
ER  -